172 related articles for article (PubMed ID: 28074079)
1. Immunotherapeutic Targeting in Autoimmune Diseases.
Janikashvili N; Samson M; Magen E; Chikovani T
Mediators Inflamm; 2016; 2016():1432702. PubMed ID: 28074079
[No Abstract] [Full Text] [Related]
2. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
Smith HR; Olson RR
J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins on the surface of lymphocytes in autoimmune disease. II. Lymphocytotoxins on the surface of lymphocytes.
Gergely P; Szegedi G; Stenszky E; Fekete B; Szabó G; Petrányi G
Acta Med Acad Sci Hung; 1974; 31(1-2):115-8. PubMed ID: 4549467
[No Abstract] [Full Text] [Related]
4. New therapies in development for autoimmune diseases: their rationale for combination treatment.
Strand V
Springer Semin Immunopathol; 2001; 23(1-2):43-61. PubMed ID: 11455860
[No Abstract] [Full Text] [Related]
5. Biological therapies directed against cells in autoimmune disease.
Hasler P
Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955
[TBL] [Abstract][Full Text] [Related]
6. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
7. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
Fox DA; McCune WJ
Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
[No Abstract] [Full Text] [Related]
8. The weight of interleukin-6 in B cell-related autoimmune disorders.
Youinou P; Jamin C
J Autoimmun; 2009; 32(3-4):206-10. PubMed ID: 19307104
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins on the surface of lymphocytes in autoimmune diseases.
Gergely P; Szegedi G; Szabó G; Fekete B; Petrányi G
Acta Med Acad Sci Hung; 1973; 30(3):227-9. PubMed ID: 4594738
[No Abstract] [Full Text] [Related]
10. Interleukin 21 as a target of intervention in autoimmune disease.
Ettinger R; Kuchen S; Lipsky PE
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.
Ostrov BE
Immunol Invest; 2015; 44(8):777-802. PubMed ID: 26575464
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy in systemic autoimmune diseases].
Held E
Internist (Berl); 1992 Feb; 33(2):90-9. PubMed ID: 1568833
[No Abstract] [Full Text] [Related]
13. [Study of isoenzymes of lymphocyte populations during controlled immunization and in autoimmune pathology].
San'ko NM; Kaliia ES; Matveĭkov GP; Levin VI
Gematol Transfuziol; 1990 Jul; 35(7):10-3. PubMed ID: 2210315
[TBL] [Abstract][Full Text] [Related]
14. Animal models of autoimmune diseases.
Burkhardt H; Kalden JR
Rheumatol Int; 1997; 17(3):91-9. PubMed ID: 9352602
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
16. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
17. [Lymphocytotoxic antibodies in autoimmune diseases].
Klingelhöfer HL; Malchow H; Havemann K; Börngen U
Verh Dtsch Ges Inn Med; 1972; 78():884-7. PubMed ID: 4665773
[No Abstract] [Full Text] [Related]
18. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
Silverman GJ; Weisman S
Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
[No Abstract] [Full Text] [Related]
19. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage.
Machleder HI; Paulus H
Surgery; 1978 Jul; 84(1):157-65. PubMed ID: 307281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
